Literature DB >> 16783759

Artificial ascites technique for percutaneous radiofrequency ablation of liver cancer adjacent to the gastrointestinal tract.

Y Kondo1, H Yoshida, S Shiina, R Tateishi, T Teratani, M Omata.   

Abstract

BACKGROUND: Percutaneous radiofrequency ablation (RFA) of liver tumours adjacent to the gastrointestinal tract is controversial. This study assessed the value of an intraperitoneal water infusion (artificial ascites) technique for percutaneous RFA of such tumours.
METHODS: Before ablation in 52 patients (55 treatments, 58 tumours), between 250 and 3000 (mean 681) ml 5 per cent glucose solution was infused into the abdominal cavity using a 14-G needle, with the aim of preventing thermal injury by separating the liver from the gastrointestinal tract.
RESULTS: There were no adverse events associated with the artificial ascites technique. In 43 (78 per cent) of the 55 treatments, the liver and gastrointestinal tract were separated successfully. In the other 12 treatments, in which the separation was not confirmed by real-time ultrasonography, there was one case of perforation of the ascending colon after RFA; adhesion of the liver and colon resulting from previous laparotomy may have been related to the injury.
CONCLUSION: Production of artificial ascites can be undertaken safely, making RFA safe and effective for hepatic tumours adjacent to the gastrointestinal tract. In patients with possible postoperative adhesions, confirmation of separation of the liver from surrounding organs is mandatory to avoid thermal injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783759     DOI: 10.1002/bjs.5374

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  27 in total

Review 1.  Image-guided percutaneous ablation therapies for hepatocellular carcinoma.

Authors:  Shuichiro Shiina
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

2.  Percutaneous microwave ablation of liver cancer adjacent to the gastrointestinal tract.

Authors:  Pei Zhou; Ping Liang; Xiaoling Yu; Yang Wang; Baowei Dong
Journal:  J Gastrointest Surg       Date:  2008-09-30       Impact factor: 3.452

3.  Case-control study of the RFA therapeutic effect of newly developed 4D US and conventional 2D US.

Authors:  Atsunori Kusakabe; Shunsuke Nojiri; Etsuko Iio; Kentaro Matsuura; Noboru Shinkai; Tomokatsu Miyaki; Takashi Joh
Journal:  J Med Ultrason (2001)       Date:  2012-07-31       Impact factor: 1.314

Review 4.  Artificial ascites is feasible and effective for difficult-to-ablate hepatocellular carcinoma.

Authors:  Chia-Chi Wang; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2015-06-25       Impact factor: 6.047

Review 5.  Local ablation for hepatocellular carcinoma in taiwan.

Authors:  Shi-Ming Lin
Journal:  Liver Cancer       Date:  2013-04       Impact factor: 11.740

Review 6.  Radiofrequency ablation of liver tumors.

Authors:  Shaunagh McDermott; Debra A Gervais
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

7.  Percutaneous radiofrequency ablation versus surgical radiofrequency ablation for malignant liver tumours: the long-term results.

Authors:  John Wong; Kit-Fai Lee; Simon Chun-Ho Yu; Paul Sing-Fun Lee; Yue-Sun Cheung; Ching-Ning Chong; Philip Ching-Tak Ip; Paul Bo-San Lai
Journal:  HPB (Oxford)       Date:  2012-11-28       Impact factor: 3.647

8.  Percutaneous ultrasound-guided radiofrequency ablation of hepatocellular carcinoma with artificially induced pleural effusion and ascites.

Authors:  Takahide Uehara; Masashi Hirooka; Kiyotaka Ishida; Atsushi Hiraoka; Teru Kumagi; Yoshiyasu Kisaka; Yoichi Hiasa; Morikazu Onji
Journal:  J Gastroenterol       Date:  2007-04-26       Impact factor: 7.527

Review 9.  Tumour ablation: technical aspects.

Authors:  Gerlig Widmann; Gerd Bodner; Reto Bale
Journal:  Cancer Imaging       Date:  2009-10-02       Impact factor: 3.909

10.  Inflammatory myofibroblastic tumor: a possible complication of percutaneous radiofrequency ablation for hepatocellular carcinoma.

Authors:  Su Hyun Lee; Se Hyung Kim; Jae Young Lee; Soo Jin Kim; Min A Kim; Joon Koo Han; Byung Ihn Choi
Journal:  Korean J Radiol       Date:  2009 Nov-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.